 | • レポートコード：QFJ1-5585 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、抗感染症療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペニシリン、スルホンアミド、アミノグリコシド、フルオロキノロン、抗真菌剤、抗原虫剤、その他）、用途別市場規模（家庭用、病院/診療所、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗感染症療法の市場動向 ・企業の競争状況、市場シェア ・抗感染症療法の種類別市場規模と予測2016-2027（ペニシリン、スルホンアミド、アミノグリコシド、フルオロキノロン、抗真菌剤、抗原虫剤、その他） ・抗感染症療法の用途別市場規模と予測2016-2027（家庭用、病院/診療所、外来手術センター、その他） ・抗感染症療法の北米市場規模2016-2027（アメリカ、カナダ） ・抗感染症療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗感染症療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗感染症療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗感染症療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories Ltd.、Cipla Ltd.、Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))、Glenmark Pharmaceuticals Limited、GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)、Lupin Limited、Panacea Biotec Limited、Novartis AG、Pfizer, Inc.、Ranbaxy Laboratories Limited、Sun Pharmaceutical Industries Limited、AstraZeneca plc、Johnson & Johnson、WOCKHARDT、F. Hoffmann-La Roche Ltd、Sanofi、Merck） ・結論 |
Anti-Infective Therapy is the infusion of antibiotic, antiviral, or antifungal drugs which are used to treat infections that do not respond to oral medications.
Market Analysis and Insights: Global Anti-Infective Therapy Market
The global Anti-Infective Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Infective Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Infective Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Infective Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Infective Therapy market.
Global Anti-Infective Therapy Scope and Market Size
Anti-Infective Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Infective Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Penicillin
Sulphonamides
Aminoglycosides
Fluoroquinolones
Antifungals
Antiprotozoal
Others
Segment by Application
Home User
Hospitals/Clinics
Ambulatory Surgery Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories Ltd.
Cipla Ltd.
Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
Glenmark Pharmaceuticals Limited
GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
Lupin Limited
Panacea Biotec Limited
Novartis AG
Pfizer, Inc.
Ranbaxy Laboratories Limited
Sun Pharmaceutical Industries Limited
AstraZeneca plc
Johnson & Johnson
WOCKHARDT
F. Hoffmann-La Roche Ltd
Sanofi
Merck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Infective Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Penicillin
1.2.3 Sulphonamides
1.2.4 Aminoglycosides
1.2.5 Fluoroquinolones
1.2.6 Antifungals
1.2.7 Antiprotozoal
1.2.8 Others
1.3 Market by Application
1.3.1 Global Anti-Infective Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Home User
1.3.3 Hospitals/Clinics
1.3.4 Ambulatory Surgery Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Infective Therapy Market Perspective (2016-2027)
2.2 Anti-Infective Therapy Growth Trends by Regions
2.2.1 Anti-Infective Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Infective Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Infective Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Infective Therapy Industry Dynamic
2.3.1 Anti-Infective Therapy Market Trends
2.3.2 Anti-Infective Therapy Market Drivers
2.3.3 Anti-Infective Therapy Market Challenges
2.3.4 Anti-Infective Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Infective Therapy Players by Revenue
3.1.1 Global Top Anti-Infective Therapy Players by Revenue (2016-2021)
3.1.2 Global Anti-Infective Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Infective Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Infective Therapy Revenue
3.4 Global Anti-Infective Therapy Market Concentration Ratio
3.4.1 Global Anti-Infective Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Infective Therapy Revenue in 2020
3.5 Anti-Infective Therapy Key Players Head office and Area Served
3.6 Key Players Anti-Infective Therapy Product Solution and Service
3.7 Date of Enter into Anti-Infective Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Infective Therapy Breakdown Data by Type
4.1 Global Anti-Infective Therapy Historic Market Size by Type (2016-2021)
4.2 Global Anti-Infective Therapy Forecasted Market Size by Type (2022-2027)
5 Anti-Infective Therapy Breakdown Data by Application
5.1 Global Anti-Infective Therapy Historic Market Size by Application (2016-2021)
5.2 Global Anti-Infective Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-Infective Therapy Market Size (2016-2027)
6.2 North America Anti-Infective Therapy Market Size by Type
6.2.1 North America Anti-Infective Therapy Market Size by Type (2016-2021)
6.2.2 North America Anti-Infective Therapy Market Size by Type (2022-2027)
6.2.3 North America Anti-Infective Therapy Market Size by Type (2016-2027)
6.3 North America Anti-Infective Therapy Market Size by Application
6.3.1 North America Anti-Infective Therapy Market Size by Application (2016-2021)
6.3.2 North America Anti-Infective Therapy Market Size by Application (2022-2027)
6.3.3 North America Anti-Infective Therapy Market Size by Application (2016-2027)
6.4 North America Anti-Infective Therapy Market Size by Country
6.4.1 North America Anti-Infective Therapy Market Size by Country (2016-2021)
6.4.2 North America Anti-Infective Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Infective Therapy Market Size (2016-2027)
7.2 Europe Anti-Infective Therapy Market Size by Type
7.2.1 Europe Anti-Infective Therapy Market Size by Type (2016-2021)
7.2.2 Europe Anti-Infective Therapy Market Size by Type (2022-2027)
7.2.3 Europe Anti-Infective Therapy Market Size by Type (2016-2027)
7.3 Europe Anti-Infective Therapy Market Size by Application
7.3.1 Europe Anti-Infective Therapy Market Size by Application (2016-2021)
7.3.2 Europe Anti-Infective Therapy Market Size by Application (2022-2027)
7.3.3 Europe Anti-Infective Therapy Market Size by Application (2016-2027)
7.4 Europe Anti-Infective Therapy Market Size by Country
7.4.1 Europe Anti-Infective Therapy Market Size by Country (2016-2021)
7.4.2 Europe Anti-Infective Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-Infective Therapy Market Size (2016-2027)
8.2 Asia-Pacific Anti-Infective Therapy Market Size by Type
8.2.1 Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Infective Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Infective Therapy Market Size by Application
8.3.1 Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Infective Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Infective Therapy Market Size by Region
8.4.1 Asia-Pacific Anti-Infective Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Infective Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Infective Therapy Market Size (2016-2027)
9.2 Latin America Anti-Infective Therapy Market Size by Type
9.2.1 Latin America Anti-Infective Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Infective Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Infective Therapy Market Size by Type (2016-2027)
9.3 Latin America Anti-Infective Therapy Market Size by Application
9.3.1 Latin America Anti-Infective Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Infective Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Infective Therapy Market Size by Application (2016-2027)
9.4 Latin America Anti-Infective Therapy Market Size by Country
9.4.1 Latin America Anti-Infective Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Infective Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Infective Therapy Market Size (2016-2027)
10.2 Middle East & Africa Anti-Infective Therapy Market Size by Type
10.2.1 Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Infective Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Infective Therapy Market Size by Application
10.3.1 Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Infective Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Infective Therapy Market Size by Country
10.4.1 Middle East & Africa Anti-Infective Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Infective Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories Ltd.
11.1.1 Abbott Laboratories Ltd. Company Details
11.1.2 Abbott Laboratories Ltd. Business Overview
11.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Introduction
11.1.4 Abbott Laboratories Ltd. Revenue in Anti-Infective Therapy Business (2016-2021)
11.1.5 Abbott Laboratories Ltd. Recent Development
11.2 Cipla Ltd.
11.2.1 Cipla Ltd. Company Details
11.2.2 Cipla Ltd. Business Overview
11.2.3 Cipla Ltd. Anti-Infective Therapy Introduction
11.2.4 Cipla Ltd. Revenue in Anti-Infective Therapy Business (2016-2021)
11.2.5 Cipla Ltd. Recent Development
11.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
11.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Details
11.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
11.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Introduction
11.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue in Anti-Infective Therapy Business (2016-2021)
11.3.5 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Development
11.4 Glenmark Pharmaceuticals Limited
11.4.1 Glenmark Pharmaceuticals Limited Company Details
11.4.2 Glenmark Pharmaceuticals Limited Business Overview
11.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Introduction
11.4.4 Glenmark Pharmaceuticals Limited Revenue in Anti-Infective Therapy Business (2016-2021)
11.4.5 Glenmark Pharmaceuticals Limited Recent Development
11.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
11.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Details
11.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
11.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Introduction
11.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue in Anti-Infective Therapy Business (2016-2021)
11.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Development
11.6 Lupin Limited
11.6.1 Lupin Limited Company Details
11.6.2 Lupin Limited Business Overview
11.6.3 Lupin Limited Anti-Infective Therapy Introduction
11.6.4 Lupin Limited Revenue in Anti-Infective Therapy Business (2016-2021)
11.6.5 Lupin Limited Recent Development
11.7 Panacea Biotec Limited
11.7.1 Panacea Biotec Limited Company Details
11.7.2 Panacea Biotec Limited Business Overview
11.7.3 Panacea Biotec Limited Anti-Infective Therapy Introduction
11.7.4 Panacea Biotec Limited Revenue in Anti-Infective Therapy Business (2016-2021)
11.7.5 Panacea Biotec Limited Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Anti-Infective Therapy Introduction
11.8.4 Novartis AG Revenue in Anti-Infective Therapy Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 Pfizer, Inc.
11.9.1 Pfizer, Inc. Company Details
11.9.2 Pfizer, Inc. Business Overview
11.9.3 Pfizer, Inc. Anti-Infective Therapy Introduction
11.9.4 Pfizer, Inc. Revenue in Anti-Infective Therapy Business (2016-2021)
11.9.5 Pfizer, Inc. Recent Development
11.10 Ranbaxy Laboratories Limited
11.10.1 Ranbaxy Laboratories Limited Company Details
11.10.2 Ranbaxy Laboratories Limited Business Overview
11.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Introduction
11.10.4 Ranbaxy Laboratories Limited Revenue in Anti-Infective Therapy Business (2016-2021)
11.10.5 Ranbaxy Laboratories Limited Recent Development
11.11 Sun Pharmaceutical Industries Limited
11.11.1 Sun Pharmaceutical Industries Limited Company Details
11.11.2 Sun Pharmaceutical Industries Limited Business Overview
11.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Introduction
11.11.4 Sun Pharmaceutical Industries Limited Revenue in Anti-Infective Therapy Business (2016-2021)
11.11.5 Sun Pharmaceutical Industries Limited Recent Development
11.12 AstraZeneca plc
11.12.1 AstraZeneca plc Company Details
11.12.2 AstraZeneca plc Business Overview
11.12.3 AstraZeneca plc Anti-Infective Therapy Introduction
11.12.4 AstraZeneca plc Revenue in Anti-Infective Therapy Business (2016-2021)
11.12.5 AstraZeneca plc Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Anti-Infective Therapy Introduction
11.13.4 Johnson & Johnson Revenue in Anti-Infective Therapy Business (2016-2021)
11.13.5 Johnson & Johnson Recent Development
11.14 WOCKHARDT
11.14.1 WOCKHARDT Company Details
11.14.2 WOCKHARDT Business Overview
11.14.3 WOCKHARDT Anti-Infective Therapy Introduction
11.14.4 WOCKHARDT Revenue in Anti-Infective Therapy Business (2016-2021)
11.14.5 WOCKHARDT Recent Development
11.15 F. Hoffmann-La Roche Ltd
11.15.1 F. Hoffmann-La Roche Ltd Company Details
11.15.2 F. Hoffmann-La Roche Ltd Business Overview
11.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Introduction
11.15.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Infective Therapy Business (2016-2021)
11.15.5 F. Hoffmann-La Roche Ltd Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Details
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Anti-Infective Therapy Introduction
11.16.4 Sanofi Revenue in Anti-Infective Therapy Business (2016-2021)
11.16.5 Sanofi Recent Development
11.17 Merck
11.17.1 Merck Company Details
11.17.2 Merck Business Overview
11.17.3 Merck Anti-Infective Therapy Introduction
11.17.4 Merck Revenue in Anti-Infective Therapy Business (2016-2021)
11.17.5 Merck Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-Infective Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Penicillin
Table 3. Key Players of Sulphonamides
Table 4. Key Players of Aminoglycosides
Table 5. Key Players of Fluoroquinolones
Table 6. Key Players of Antifungals
Table 7. Key Players of Antiprotozoal
Table 8. Key Players of Others
Table 9. Global Anti-Infective Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Anti-Infective Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Anti-Infective Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Anti-Infective Therapy Market Share by Regions (2016-2021)
Table 13. Global Anti-Infective Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Anti-Infective Therapy Market Share by Regions (2022-2027)
Table 15. Anti-Infective Therapy Market Trends
Table 16. Anti-Infective Therapy Market Drivers
Table 17. Anti-Infective Therapy Market Challenges
Table 18. Anti-Infective Therapy Market Restraints
Table 19. Global Anti-Infective Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Anti-Infective Therapy Market Share by Players (2016-2021)
Table 21. Global Top Anti-Infective Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Therapy as of 2020)
Table 22. Ranking of Global Top Anti-Infective Therapy Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Anti-Infective Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Anti-Infective Therapy Product Solution and Service
Table 26. Date of Enter into Anti-Infective Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Anti-Infective Therapy Revenue Market Share by Type (2016-2021)
Table 30. Global Anti-Infective Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Anti-Infective Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Anti-Infective Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Anti-Infective Therapy Revenue Market Share by Application (2016-2021)
Table 34. Global Anti-Infective Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Anti-Infective Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Anti-Infective Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Anti-Infective Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Anti-Infective Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Anti-Infective Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Anti-Infective Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Anti-Infective Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Anti-Infective Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Anti-Infective Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Anti-Infective Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Anti-Infective Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 66. Abbott Laboratories Ltd. Company Details
Table 67. Abbott Laboratories Ltd. Business Overview
Table 68. Abbott Laboratories Ltd. Anti-Infective Therapy Product
Table 69. Abbott Laboratories Ltd. Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 70. Abbott Laboratories Ltd. Recent Development
Table 71. Cipla Ltd. Company Details
Table 72. Cipla Ltd. Business Overview
Table 73. Cipla Ltd. Anti-Infective Therapy Product
Table 74. Cipla Ltd. Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 75. Cipla Ltd. Recent Development
Table 76. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Details
Table 77. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
Table 78. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product
Table 79. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 80. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Development
Table 81. Glenmark Pharmaceuticals Limited Company Details
Table 82. Glenmark Pharmaceuticals Limited Business Overview
Table 83. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product
Table 84. Glenmark Pharmaceuticals Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 85. Glenmark Pharmaceuticals Limited Recent Development
Table 86. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Details
Table 87. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
Table 88. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product
Table 89. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Development
Table 91. Lupin Limited Company Details
Table 92. Lupin Limited Business Overview
Table 93. Lupin Limited Anti-Infective Therapy Product
Table 94. Lupin Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 95. Lupin Limited Recent Development
Table 96. Panacea Biotec Limited Company Details
Table 97. Panacea Biotec Limited Business Overview
Table 98. Panacea Biotec Limited Anti-Infective Therapy Product
Table 99. Panacea Biotec Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 100. Panacea Biotec Limited Recent Development
Table 101. Novartis AG Company Details
Table 102. Novartis AG Business Overview
Table 103. Novartis AG Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 104. Novartis AG Recent Development
Table 105. Pfizer, Inc. Company Details
Table 106. Pfizer, Inc. Business Overview
Table 107. Pfizer, Inc. Anti-Infective Therapy Product
Table 108. Pfizer, Inc. Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 109. Pfizer, Inc. Recent Development
Table 110. Ranbaxy Laboratories Limited Company Details
Table 111. Ranbaxy Laboratories Limited Business Overview
Table 112. Ranbaxy Laboratories Limited Anti-Infective Therapy Product
Table 113. Ranbaxy Laboratories Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 114. Ranbaxy Laboratories Limited Recent Development
Table 115. Sun Pharmaceutical Industries Limited Company Details
Table 116. Sun Pharmaceutical Industries Limited Business Overview
Table 117. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product
Table 118. Sun Pharmaceutical Industries Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 119. Sun Pharmaceutical Industries Limited Recent Development
Table 120. AstraZeneca plc Company Details
Table 121. AstraZeneca plc Business Overview
Table 122. AstraZeneca plc Anti-Infective Therapy Product
Table 123. AstraZeneca plc Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 124. AstraZeneca plc Recent Development
Table 125. Johnson & Johnson Company Details
Table 126. Johnson & Johnson Business Overview
Table 127. Johnson & Johnson Anti-Infective Therapy Product
Table 128. Johnson & Johnson Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 129. Johnson & Johnson Recent Development
Table 130. WOCKHARDT Company Details
Table 131. WOCKHARDT Business Overview
Table 132. WOCKHARDT Anti-Infective Therapy Product
Table 133. WOCKHARDT Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 134. WOCKHARDT Recent Development
Table 135. F. Hoffmann-La Roche Ltd Company Details
Table 136. F. Hoffmann-La Roche Ltd Business Overview
Table 137. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product
Table 138. F. Hoffmann-La Roche Ltd Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 139. F. Hoffmann-La Roche Ltd Recent Development
Table 140. Sanofi Company Details
Table 141. Sanofi Business Overview
Table 142. Sanofi Anti-Infective Therapy Product
Table 143. Sanofi Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 144. Sanofi Recent Development
Table 145. Merck Company Details
Table 146. Merck Business Overview
Table 147. Merck Anti-Infective Therapy Product
Table 148. Merck Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
Table 149. Merck Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Infective Therapy Market Share by Type: 2020 VS 2027
Figure 2. Penicillin Features
Figure 3. Sulphonamides Features
Figure 4. Aminoglycosides Features
Figure 5. Fluoroquinolones Features
Figure 6. Antifungals Features
Figure 7. Antiprotozoal Features
Figure 8. Others Features
Figure 9. Global Anti-Infective Therapy Market Share by Application: 2020 VS 2027
Figure 10. Home User Case Studies
Figure 11. Hospitals/Clinics Case Studies
Figure 12. Ambulatory Surgery Centres Case Studies
Figure 13. Others Case Studies
Figure 14. Anti-Infective Therapy Report Years Considered
Figure 15. Global Anti-Infective Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Anti-Infective Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Anti-Infective Therapy Market Share by Regions: 2020 VS 2027
Figure 18. Global Anti-Infective Therapy Market Share by Regions (2022-2027)
Figure 19. Global Anti-Infective Therapy Market Share by Players in 2020
Figure 20. Global Top Anti-Infective Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Therapy as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Anti-Infective Therapy Revenue in 2020
Figure 22. Global Anti-Infective Therapy Revenue Market Share by Type (2016-2021)
Figure 23. Global Anti-Infective Therapy Revenue Market Share by Type (2022-2027)
Figure 24. North America Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Anti-Infective Therapy Market Share by Type (2016-2027)
Figure 26. North America Anti-Infective Therapy Market Share by Application (2016-2027)
Figure 27. North America Anti-Infective Therapy Market Share by Country (2016-2027)
Figure 28. United States Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Anti-Infective Therapy Market Share by Type (2016-2027)
Figure 32. Europe Anti-Infective Therapy Market Share by Application (2016-2027)
Figure 33. Europe Anti-Infective Therapy Market Share by Country (2016-2027)
Figure 34. Germany Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Anti-Infective Therapy Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Anti-Infective Therapy Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Anti-Infective Therapy Market Share by Region (2016-2027)
Figure 44. China Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Anti-Infective Therapy Market Share by Type (2016-2027)
Figure 52. Latin America Anti-Infective Therapy Market Share by Application (2016-2027)
Figure 53. Latin America Anti-Infective Therapy Market Share by Country (2016-2027)
Figure 54. Mexico Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Anti-Infective Therapy Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Anti-Infective Therapy Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Anti-Infective Therapy Market Share by Country (2016-2027)
Figure 60. Turkey Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Laboratories Ltd. Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 64. Cipla Ltd. Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 65. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 66. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 67. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 68. Lupin Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 69. Panacea Biotec Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 70. Novartis AG Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 71. Pfizer, Inc. Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 72. Ranbaxy Laboratories Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 73. Sun Pharmaceutical Industries Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 74. AstraZeneca plc Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 75. Johnson & Johnson Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 76. WOCKHARDT Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 77. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 78. Sanofi Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 79. Merck Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の長寿＆老化防止治療市場規模・現状・予測（2021年-2027年） Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…- 世界の抗腫瘍療法市場規模・現状・予測（2021年-2027年） Anti-neoplastic therapy refers to the therapy which aims to prevent, inhibit or halt the development of a neoplasm. Market Analysis and Insights: Global Anti-Neoplastic Therapy Market The global Anti-Neoplastic Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in …
- 世界の抗老化療法市場規模・現状・予測（2021年-2027年） Various biomolecules in the system have a large number of active groups, which must interact with each other to produce chemical reactions and slowly cross-link the biomolecules so as to stabilize the chemical activity.With the passage of time, the degree of crosslinking keeps increasing, the consum…
- 長寿及び抗老化療法のグローバル市場：規模・現状・予測2019-2025 Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…
- 長寿及び抗老化療法のグローバル市場：規模・現状・予測2019-2025 Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…